BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 27929505)

  • 21. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction.
    Nesvacil N; Pötter R; Sturdza A; Hegazy N; Federico M; Kirisits C
    Radiother Oncol; 2013 Apr; 107(1):75-81. PubMed ID: 23068712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient's specific integration of OAR doses (D2 cc) from EBRT and 3D image-guided brachytherapy for cervical cancer.
    Gelover E; Katherine C; Mart C; Sun W; Kim Y
    J Appl Clin Med Phys; 2018 Mar; 19(2):83-92. PubMed ID: 29349933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of dosimetric impact of inter-application and intra-application variations in fractionated high-dose-rate intra-cavitary brachytherapy of cervical cancer.
    Pasha T; Hassan HN; Radhakrishna N; N MS; Varghese AS; Viswanath L; Valuvil NB; S S; H B G; Khaleel I; Palled SR; Thimmaiah N
    J Contemp Brachytherapy; 2021 Dec; 13(6):627-632. PubMed ID: 35079248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of organs at risk doses in GYN intracavitary brachytherapy for different tandem lengths and bladder volumes.
    Siavashpour Z; Aghamiri MR; Jaberi R; ZareAkha N; Manshadi HRD; Kirisits C; Sedaghat M
    J Appl Clin Med Phys; 2016 May; 17(3):5-13. PubMed ID: 27167253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative evaluation of two dose optimization methods for image-guided, highly-conformal, tandem and ovoids cervix brachytherapy planning.
    Ren J; Menon G; Sloboda R
    Phys Med Biol; 2013 Apr; 58(7):2045-58. PubMed ID: 23459004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
    Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
    Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer.
    Mohamed S; Nielsen SK; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Radiother Oncol; 2013 Apr; 107(1):32-8. PubMed ID: 23333020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users.
    Nomden CN; de Leeuw AA; Van Limbergen E; de Brabandere M; Nulens A; Nout RA; Laman M; Ketelaars M; Lutgens L; Reniers B; Jürgenliemk-Schulz IM
    Radiother Oncol; 2013 Apr; 107(1):82-7. PubMed ID: 23127774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer.
    Ohkubo Y; Ohno T; Noda SE; Kubo N; Nakagawa A; Kawahara M; Abe T; Kiyohara H; Wakatsuki M; Nakano T
    J Radiat Res; 2013 Nov; 54(6):1138-45. PubMed ID: 23732770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anatomy-based definition of point A utilizing three-dimensional volumetric imaging approach for high-dose-rate (HDR) intracavitary brachytherapy dose prescription when treating cervical cancer using limited resources.
    Goyal MK; Rai DV; Kehwar TS; Manjhi J; Heintz BH; Shide KL; Barker JL
    J Appl Clin Med Phys; 2016 Jul; 17(6):69-77. PubMed ID: 27929482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
    Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy.
    Zolciak-Siwinska A; Kowalczyk A; Sikorska K; Bijok M; Michalski W; Gruszczynska E
    Brachytherapy; 2018; 17(4):667-672. PubMed ID: 29764769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
    Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
    Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans.
    Bondar ML; Hoogeman MS; Mens JW; Quint S; Ahmad R; Dhawtal G; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1617-23. PubMed ID: 22270164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
    Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
    Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calculation of dose volume parameters and indices in plan evaluation of HDR interstitial brachytherapy by MUPIT in carcinoma cervix.
    Poddar J; Sharma AD; Suryanarayan U; Shah SP; Parikh A; Mehta V; Kumar T
    Indian J Cancer; 2018; 55(3):238-241. PubMed ID: 30693886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Accuracy of different image registration methods in image-guided adaptive brachytherapy for cervical cancer].
    Peng Q; Peng Y; Zhu J; Cai M; Zhou L
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1344-1348. PubMed ID: 30514683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
    Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.